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ARTICLE
A minimal biochemical route towards de novo
formation of synthetic phospholipid membranes
Ahanjit Bhattacharya1, Roberto J. Brea 1, Henrike Niederholtmeyer 1 & Neal K. Devaraj 1
All living cells consist of membrane compartments, which are mainly composed of phos-
pholipids. Phospholipid synthesis is catalyzed by membrane-bound enzymes, which them-
selves require pre-existing membranes for function. Thus, the principle of membrane
continuity creates a paradox when considering how the first biochemical membrane-
synthesis machinery arose and has hampered efforts to develop simplified pathways for
membrane generation in synthetic cells. Here, we develop a high-yielding strategy for de
novo formation and growth of phospholipid membranes by repurposing a soluble enzyme
FadD10 to form fatty acyl adenylates that react with amine-functionalized lysolipids to form
phospholipids. Continuous supply of fresh precursors needed for lipid synthesis enables the
growth of vesicles encapsulating FadD10. Using a minimal transcription/translation system,
phospholipid vesicles are generated de novo in the presence of DNA encoding FadD10. Our
findings suggest that alternate chemistries can produce and maintain synthetic phospholipid
membranes and provides a strategy for generating membrane-based materials.
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Phospholipids are the primary constituents of cell mem-branes. In living organisms, phospholipids are generatedenzymatically by the reaction of a polar head group with
long-chain acyl derivatives. These key steps rely on integral
membrane proteins, such as acyltransferases, which require pre-
existing membranes for proper folding and function1 (Fig. 1a).
This mechanism implies that all biological membranes must arise
from pre-existing membranes2. However, the principle of biolo-
gical membrane continuity presents a challenge for explaining
how phospholipid membranes were generated de novo before the
current membrane-dependent enzymes and mechanisms for
phospholipid synthesis developed. We reasoned that designing a
minimal route for enzymatic de novo phospholipid synthesis
could help us understand how early cellular membrane synthe-
sizing machinery evolved3–5. Since present-day integral mem-
brane proteins cannot carry out true de novo phospholipid
formation, a method by which a soluble enzyme could facilitate
the synthesis of membrane-forming phospholipids is required. It
can also provide simplified strategies for generating membrane
compartments in synthetic cells6–9, enable the development of
tools for reconstituting membrane proteins10,11, and facilitate
strategies for synthesizing structured lipids12.
As there are no analogous reactions in biology, we sought to
design a unique lipid synthesizing system by repurposing a soluble
mycobacterial ligase, FadD1013 for phospholipid formation
(Fig. 1b). FadD10 catalyzes the generation of fatty acyl adenylates
(FAAs) from fatty acid, Mg2+, and ATP precursors. Acyl adeny-
lates (AAs)— metabolic intermediates found in diverse bio-
chemical pathways in both prokaryotes and eukaryotes, typically
undergo enzymatic coupling with thiol nucleophiles, such as
coenzyme A (CoA)14. AAs and other acyl phosphates can also
react non-enzymatically with primary amines in aqueous
media15,16. Therefore, we hypothesized that an FAA could spon-
taneously react with an amine-functionalized lipid fragment to
produce a membrane-forming phospholipid (Fig. 1c).
Here, we show that FadD10 can mediate the de novo genera-
tion of phospholipid molecules from water-soluble single-chain
amphiphilic precursors. The FAAs generated by FadD10 react
chemoselectively with amine-functionalized lysolipids to form
phospholipids that self-assemble to form membranes. This
demonstrates that pathways radically different from those taking
place in living cells may be developed for synthesizing
membrane-forming materials.
Results
Reactivity of fatty acyl adenylates (FAA). In order to evaluate the
scope and applicability of the proposed lipid synthesis pathway,
we first explored the reactivity patterns of FAAs. We synthesized
dodecanoyl-AMP 117 (Supplementary Figs. 1–4) as a model FAA,
and found that it was fairly stable to hydrolysis at 37 °C in 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer,
pH 7.5 in the absence or presence (10mM) of Mg2+, and over
time scales relevant to our subsequent experiments (Supplemen-
tary Fig. 5a). We observed that 1 showed negligible reactivity
toward the hydroxy groups of the naturally occurring lysolipids 1-
oleoyl-2-hydroxy-sn-glycero-3-phosphocholine (Lyso C18:1 PC-
OH) and 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
(Lyso C16:0 PC-OH) (Supplementary Fig. 5b). Remarkably, when
we mixed 1 with the corresponding amine-functionalized lysoli-
pids 2 (Fig. 1c and Supplementary Figs. 1–4) or 4 (Fig. 1c and
Supplementary Figs. 1–4) in HEPES buffer, pH 7.5 at 37 °C,
the solution became turbid after 20min, and we observed
the formation of a large population of vesicles (Supplementary
Fig. 6 and Supplementary Movie 1). The progress of the reaction
between 1 and 2 was analyzed over time using liquid
chromatography–mass spectrometry (LC–MS) measurements
(Fig. 1d). The second-order rate constant for the reaction was
determined to be 87.0 ± 9.1M−1·s−1 (Supplementary Fig. 5c, error
value represents standard deviation from n= 3 replicates). We
obtained the nuclear magnetic resonance (NMR) spectra from
purified phospholipids 3 and 5. These data verified that acylation
occurred at the primary amine functionality of 2 and 4, respectively.
Because amines are ubiquitous in biology, we asked if FAAs
have any selectivity for amine-functionalized lysolipids over
simple water-soluble amines. When the reaction between 1 and 2
was conducted in the presence of 50 mM lysine in HEPES buffer,
we found that coupling occurred with excellent selectivity
between the FAA and the lysolipid. We did not observe
significant side products that corresponded to a reaction with
the primary amine groups in lysine (Fig. 1e and Supplementary
Fig. 5d). We found similar selectivity when the coupling reaction
between 1 and 2 was carried out in 100 mM 2-amino-2-
hydroxymethyl-propane-1,3-diol (Tris) buffer, pH 8.0 (Supple-
mentary Fig. 5e). We followed the reaction kinetics between 1 and
a non-amphiphilic primary amine, Fmoc-L-Lys-OH, by HPLC-
MS. The second order rate constant for the reaction was obtained
to be 0.0033 ± 0.0004M−1·s−1 (error value represents standard
deviation from n= 3 replicates), almost 30,000-fold slower than
the reaction with the lysolipid 2 (Supplementary Fig. 5f). We
attribute this high selectivity of phospholipid synthesis to
hydrophobic interactions between the alkyl chains of 1 and 2,
which are brought into close proximity, likely within mixed
micelles or formed lipid membranes. These reactivity patterns
indicate that FAAs could serve as an activated acyl precursor in a
more complex biochemically relevant media.
De novo phospholipid formation mediated by FadD10. We
next aimed to identify an appropriate enzyme capable of gen-
erating FAAs, such as 1 from fatty acid and ATP precursors. In
biological systems, fatty acids are activated to FAAs by various
fatty acyl CoA ligases (FACLs) and fatty acyl adenylate ligases
(FAALs)14. While FACLs are common, the FAA intermediate
remains tightly bound to the active site to facilitate its subsequent
reaction with CoA, which limited their attractiveness as candidate
enzymes. We sought an enzyme that could form FAAs that could
subsequently react with amine-functionalized lysolipids. We
selected FadD1018, a recently characterized FAAL involved in the
biosynthesis of a putative lipopeptide virulence factor in Myco-
bacterium tuberculosis19. FadD10 is a soluble enzyme that con-
verts long-chain saturated fatty acids (typically C12–C16) into
corresponding FAAs in presence of ATP and Mg2+. Since
FadD10 displays an “open” conformation of its active site, it does
not have a high binding affinity to the FAA product18. As such,
we hypothesized the newly synthesized FAAs will be free to dif-
fuse away and react with amine-functionalized lysolipids to form
the corresponding amidophospholipids.
We expressed N-terminal His6-tagged FadD10 in E. coli and
purified it according to a published procedure18. In a typical
phospholipid synthesis reaction, FadD10 was incubated with
ATP, MgCl2, lysolipid 2, and sodium dodecanoate in HEPES
buffer at 37 °C. The enzymatically formed FAA intermediate 1
was detected by HPLC-MS, even after FadD10 was separated
from the reaction mixture by spin filtration (Supplementary
Fig. 7a, b). These results indicate that 1 was released from the
enzyme’s active site. Approximately 30 min after mixing FadD10
and substrates, small vesicles could be detected by optical
microscopy. These vesicles gradually transformed into larger
vesicles of various sizes and lamellarity (Fig. 2a, Supplementary
Fig. 8). We followed the progress of de novo formation of
phospholipid membranes using a well-established Fluorescence
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Resonance Energy Transfer (FRET) assay involving fluorescently
labeled phospholipid probes20. We observed a linear increase in
the ratio of the fluorescence intensities of the donor dye NBD-
DHPE (λex: 430 nm, λem: 530 nm) and the acceptor dye
Rhodamine-DHPE (λex: 430 nm, λem: 586 nm), suggesting that
membrane growth is taking place during phospholipid synthesis
(Supplementary Fig. 9). In a control experiment, where GTP was
substituted for ATP, a nearly constant ratio of the donor and
acceptor fluorescence intensities was observed, consistent with the
lack of phospholipid formation.
In addition, we performed several control experiments where
one of the key reaction components was omitted or replaced by
an unreactive substitute to confirm that vesicle formation
occurred due to phospholipid generation (Supplementary
Fig. 10a–c). Cryo-electron microscopy further verified the
presence of membranes (Fig. 2b). We analyzed the formation of
phospholipid 3 using HPLC-MS and found that the precursors
were almost completely consumed in about 8 h (Fig. 2c). In order
to test the broader applicability of our method, we carried out the
reaction in presence of the amine-functionalized lysophosphati-
dylglycerol 6 (Supplementary Figs. 1–3). We obtained the bilayer
forming phospholipid 7, which self-assembled to form vesicles as
well (Supplementary Fig. 11).
Interestingly, when we used Alexa Fluor® 488-labeled FadD10,
we observed that the enzyme was significantly associated with the
de novo-formed phospholipid 3 membranes (Fig. 2d and
Supplementary Fig. 12a). We isolated the vesicles from the
reaction mixture by spin filtration and subsequent SDS–PAGE
analysis of the vesicle fraction showed the presence of FadD10
(Supplementary Fig. 12b). Further investigation using unilamellar
vesicles encapsulating fluorescently labeled FadD10 and ATP
showed that the enzyme gradually associated with the membranes
when dodecanoic acid and lysolipid 4 were slowly supplied from
the outside (Supplementary Fig. 12c, d and Supplementary
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Fig. 1 De novo formation of phospholipid membranes based on adenylate chemistry. a A representative phospholipid biosynthetic pathway (Kennedy
pathway), which involves multiple membrane-bound enzyme-catalyzed steps, substrates and cofactors [GPAT, glycerol-3-phosphate acyl transferase;
LPAAT, lysophosphatidic acid acyl transferase; G3P, glycerol 3-phosphate; CoA, coenzyme A; FACoA, fatty acyl coenzyme A; LPA, lysophosphatidic acid;
PA, phosphatidic acid; PL, phospholipid]. b The proposed synthetic pathway of phospholipids, which involves a single soluble enzyme FadD10 and reactive
lipid precursors [DDA, dodecanoic acid]. c De novo synthesis of phospholipids (3 or 5) by chemoselective reaction of the model FAA dodecanoyl-AMP (1)
and amine-functionalized lysolipids (2 or 4). d Kinetics of phospholipid 3 (open black triangles, red line) formation by the reaction of FAA 1 with lysolipid 2
(open black circles, blue line). Integrated HPLC peak areas (205 nm) from three experiments were used to monitor the progress of the reaction. e HPLC/
ELSD traces monitoring the selective formation of phospholipid 3 by reaction of FAA 1 and lysolipid 2 in the presence of 50mM lysine
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Movie 2). These data suggest that FadD10 associates with the
membranes possibly through electrostatic interaction with the
charged amphiphilic precursors. Given that the theoretical
isoelectric point (pI) of His6-FadD10 is 5.4 (ExPASy), it is likely
to bear a negative charge in the pH range of our experiments and
undergo electrostatic interactions with the positively charged
amine-functionalized lysolipid to become encapsulated during de
novo formation of phospholipid vesicles.
Microfluidics experiments. Since FadD10 could facilitate the de
novo formation of phospholipids, we determined if vesicles
encapsulating FadD10 could generate additional phospholipids if
we continuously supplied reactive precursors. We expected to
observe membrane growth and the formation of new vesicles
occurring if lipid synthesis is efficient. Since continual feeding of
substrates requires maintaining non-equilibrium steady-state
conditions for extended periods of time, we utilized a microfluidic
chip21 (Fig. 3a) to trap giant vesicles (Fig. 3b; see Supplementary
Fig. 13a–f for full characterization) composed of phospholipid 3
encapsulating Alexa Fluor® 488-labeled FadD10 and ATP. We
then continuously flowed reactive precursors (lysolipid 4, sodium
dodecanoate, ATP, and MgCl2 in HEPES buffer) for 12 h with
simultaneous imaging (Fig. 3a). In all experiments, we carefully
matched the osmolarities of the initial vesicle dispersion and the
flow solution using an osmometer in order to minimize non-
specific effects on membrane morphology22,23 arising from
osmotic mismatch. During the first few hours, the vesicles
underwent drastic morphological transformations followed by
growth (Fig. 3c and Supplementary Fig. 14a–c and Supplemen-
tary Movies 3 and 4). Some vesicles exhibited membrane growth
that promoted division into smaller vesicles, while maintaining
their internal content, as observed using the fluorescence signal
from labeled FadD10 (Fig. 3d and Supplementary Fig. 15a, b and
Supplementary Movies 5 and 6). This mode of division resembles
that in L-form bacteria, where excess membrane synthesis
increases the cellular surface-area-to-volume ratio to produce
proliferation and budding events24. The addition of amphiphilic
precursors likely enhanced the permeability of the membranes to
polar solutes such as ATP due to formation of local non-lamellar
phases25 or transient defects26–28 similar to what has been
observed in previous works.
In a subsequent experiment, we replaced the amine-
functionalized lysolipid 4 with Lyso C16:0 PC-OH, a lysolipid
unreactive toward 1 (n= 3; Supplementary Fig. 5b and
Supplementary Movie 7). During the first 5 h, the vesicles
underwent minor structural deformations without significant
changes in size. The vesicles then started to solubilize likely due to
surfactant action29,30. The chambers were depleted of vesicles
over the next 3 h. In a separate experiment (described
in Supplementary Methods), we simulated the conditions in the
microfluidic device by slowly adding reactive precursors (lysolipid
4, sodium dodecanoate, ATP, and MgCl2 in HEPES buffer) to the
giant vesicles encapsulating FadD10 and ATP using a syringe
pump and observed the formation of new phospholipid 5 over
time by HPLC-MS (Fig. 3e). These results demonstrate that the
vesicle growth and division events we observed in the
microfluidic device were the result of the synthesis of new
phospholipid, and not simply due to incorporation of amphi-
philic precursors to the membranes.
Linking gene expression to phospholipid membrane forma-
tion. Functional synthetic cells require coupled gene expression
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Fig. 2 FadD10 mediated de novo formation and assembly of phospholipid membranes. a Time series of spinning disk confocal microscopy images depicting
de novo phospholipid 3 vesicle formation resulting from the incubation of an aqueous solution of dodecanoic acid, lysolipid 2, ATP, MgCl2, FadD10, and 0.1
mol% Texas Red® DHPE at 37 °C. Scale bar: 10 µm. b Cryogenic-transmission electron microscopy (cryo-TEM) image of a de novo formed phospholipid
vesicle showing the presence of membranes. Scale bar: 100 nm. c Kinetics of the consumption of lysolipid 2 (open black circles, blue line) and formation of
phospholipid 3 (open black triangles, red line) at 37 °C. Integrated HPLC peak areas (205 nm) from three experiments were used to monitor the progress
of the reaction. d Spinning disk confocal microscopy images of phospholipid 3 vesicles formed with Alexa Fluor® 488-labeled FadD10 and 0.1 mol% Texas
Red® DHPE, showing association of the enzyme with the membrane. Scale bar: 10 µm
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Fig. 3 Membrane growth and division in a microfluidic device. a Schematic representation of a microfluidic chip utilized to entrap phospholipid 3 giant
vesicles encapsulating Alexa Fluor® 488-labeled FadD10 and ATP. Reactive precursors (dodecanoic acid, lysolipid 4, ATP, and MgCl2) were continuously
flowed with simultaneous spinning disk confocal microscopy. Scale bar: 50 µm. b Cryo-transmission electron microscopy (cryo-TEM) image of a large
multilamellar vesicle prepared as per the vesicles used for the microfluidics experiments. Note the presence of abundant internal membranes. Scale bar:
100 nm. c Fluorescence microscopy images (Texas Red® channel) corresponding to vesicle growth over time. Scale bar: 10 µm. See Supplementary
Movie 3. d Fluorescence microscopy images (Texas Red® channel) corresponding to vesicle division. The yellow arrows indicate the formation and
departure of a daughter vesicle. Scale bar: 20 µm. Inset depicts the daughter vesicle in the Alexa Fluor® 488 channel. In c and d, the images are scaled
logarithmically to enhance visibility of internal membranous structures. See Supplementary Movie 4. e HPLC-MS experiment demonstrating formation of
phospholipid 5 (indicated in red arrow) upon addition of lysolipid 4 and other precursors to phospholipid 3 giant vesicles encapsulating FadD10
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Fig. 4 Linking gene expression of FadD10 to phospholipid synthesis. a Schematic representation of the cell-free expression of FadD10 and subsequent
assembly of the de novo synthesized phospholipid into vesicles in the presence of appropriate reactive precursors [TX-TL: transcription/translation].
b SDS–PAGE analysis of the expression of FadD10 in the PURExpress® System. Lane L1: No DNA; Lane L2: DHFR DNA; Lane L3: FadD10 DNA. c HPLC/
ELSD traces monitoring the formation of phospholipid 3 by incubation of PURExpress® System with an aqueous solution of dodecanoic acid, lysolipid 2, ATP
and MgCl2 at 37 °C in the absence (gray line) or presence (orange line) of plasmid DNA coding for FadD10. d Spinning disk confocal microscopy of the
in situ formed phospholipid vesicles in the PURExpress® System driven by FadD10 expression. Membranes were stained using 0.1 mol% Texas Red® DHPE
dye. Scale bar: 5 µm. e Localization of sfGFP-FadD10 to the membrane of the vesicles formed upon addition of the plasmid encoding the former into PURE
system. External proteins were digested by Proteinase K. Scale bar: 5 µm
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and membrane formation to enable genetic circuits and sensors to
effect cell membrane growth. We therefore linked the expression
of FadD10 to lipid synthesis using a cell-free protein expression
system (Fig. 4a). In a typical reaction, plasmid DNA encoding
FadD10 was first added to the PURExpress® System, a minimal
recombinant transcription/translation system. We confirmed
FadD10 expression by SDS–PAGE (Fig. 4b, Supplementary
Fig. 16a). Then, we added lipid precursors and incubated the
mixture at 37 °C for 3–6 h. HPLC-ELSD traces of the reaction
mixture indicated that phospholipid 3 was formed, and no
lysolipid 2 was detectable (Fig. 4c). This result demonstrates that
FAAs can be continuously generated in a complex medium, such
as PURE system, and subsequently react with an amine-
functionalized lysolipid to form the corresponding phospholi-
pid. We observed a large number of vesicles in the reaction
mixture using microscopy (Fig. 4d and Supplementary Fig. 13c).
When we omitted FadD10 DNA, no phospholipid synthesis
occurred (Fig. 4c), and no vesicles were observed (Supplementary
Fig. 16b). When we replicated the experiment using a plasmid
encoding sfGFP fused to FadD10 (Supplementary Fig. 17a–d for
characterization, Supplementary Table 1 for primers), we found
that the enzyme was spontaneously associated with the de novo
formed membranes (Fig. 4e). These results suggest that expres-
sion of FadD10 will enable the coupling of genotype with
membrane growth in synthetic cells.
Discussion
In summary, we have developed an efficient and minimal bio-
chemical route to synthesize phospholipids by repurposing the
activity of a single enzyme. Our strategy of using a soluble
enzyme to promote phospholipid formation has a distinct
advantage over previously described methods using integral
membrane proteins27,31,32. The latter are difficult to reconstitute
and require pre-existing membranes for maintaining proper
structure and function. A method that relies on a soluble enzyme
could be more straightforward and effective in linking genetic
circuits with membrane formation in artificial cells.
Finally, our results also shed light on possible mechanisms
leading to the origins of modern cellular membranes. Although it
is believed that the earliest protocell membranes were composed
of simple single-chain amphiphiles derived from geochemical
processes33, there is still no consensus on how complex lipid
synthesis arose during evolution. It has been hypothesized that
phospholipid synthesis may have arisen in the RNA-world4. If so,
then a ribozyme capable of driving phospholipid synthesis would
be required5. If ribozymes were to closely mimic the function of
natural lipid synthesizing acyltransferases, they would most likely
be membrane-bound to interact effectively with their lipid sub-
strates. This possibility seems unlikely, since RNAs are highly
charged and polar, which makes them unlikely to embed catalytic
centers within lipid membranes34. Our approach suggests an
alternative scenario. Early ribozymes may have evolved to activate
single-chain precursors, such as fatty acids into corresponding
acyl adenylates. The coupling of such activated precursors to
other single-chain amphiphiles may have occurred sponta-
neously, either in micelles or within membranes. Indeed, a
ribozyme capable of synthesizing acyl phosphates has previously
been identified35, and the prebiotic plausibility of a single-chain
phosphorylated amino amphiphile has been suggested36 (see
Supplementary Fig. 18 for reaction scheme). If fatty acyl adeny-
late synthesizing ribozymes could be selected through directed
evolution and used to drive the de novo formation of membrane-
forming lipids, it would suggest that catalysis by a soluble mac-
romolecule could have played an important role in the early
evolution of complex cellular membranes.
The use of soluble enzymes to efficiently generate membrane-
forming lipids, de novo could have numerous applications. There
is tremendous interest in the development of synthetic cells37–39,
and advanced synthetic cells will undoubtedly require simplified
methods to generate and maintain phospholipid membranes40,41.
Our system provides a means to link gene expression and lipid
formation in a synthetic cell. We also envision that the metho-
dology of enzymatic de novo phospholipid membrane formation
will enable synthesis of specific lipids in a cellular milieu, by
expressing FadD10 and providing the reactive precursors. Finally,
our method provides a route to synthesize proteoliposomes,
which could have applications in biomaterials design and the
reconstitution of disease-relevant membrane-bound proteins10,11.
Methods
HPLC-ELSD-MS analyses. Solvent mixtures for chromatography are reported as
volume/volume (v/v) ratios. HPLC analyses were performed with an Eclipse Plus
C8 analytical column with gradients based on Phase A and Phase B (where Phase
A: H2O with 0.1% formic acid; Phase B: MeOH with 0.1% formic acid). For
purification purposes, Zorbax SB-C18 semi-preparative column was used with
gradients based on Phase A and Phase B gradients (where Phase A: H2O with 0.1%
formic acid; Phase B: MeOH with 0.1% formic acid). Agilent 6230 Accurate-Mass
TOFMS mass spectrometer was used to obtain electrospray ionization-time-of-
flight (ESI-TOF) mass spectra. A Varian 380-LC detector was used to record ELSD
chromatograms.
NMR spectroscopy. Proton nuclear magnetic resonance (1H NMR) spectra were
acquired on a Varian VX-500 MHz or Jeol Delta ECA-500MHz spectrometers, and
were referenced relative to residual proton resonances in CDCl3 (at δ 7.24 ppm),
d6-DMSO (at δ 2.50 ppm), or CD3OD (at δ 4.87 or 3.31 ppm). Chemical shifts were
reported in parts per million (ppm, δ) relative to tetramethylsilane (δ 0.00). The
splitting patterns in 1H NMR are designated as singlet (s), doublet (d), triplet (t),
quartet (q), or pentuplet (p). All first-order splitting patterns were designated based
on the appearance of the multiplet. Splitting patterns that could not be interpreted
readily are assigned as multiplet (m) or broad (br). 13C NMR spectra were recorded
on a Varian VX-500MHz or Jeol Delta ECA-500MHz spectrometers, and were
referenced relative to residual proton resonances in CDCl3 (at δ 77.23 ppm),
CD3OD (at δ 49.15 ppm), or d6-DMSO (at δ 39.51 ppm). 1H and 13C NMR spectra
for compounds 1–6 and various synthetic intermediates (8–11) are provided in the
Supplementary Figs. 19–28.
Synthesis of dodecanoyl-AMP (1). At first, anhydrous Et2O (7 mL) was used to
dissolve solid dodecanoic acid (241.2 mg, 1.20 mmol) and stirred for 10 min at RT.
Then, a 1 M solution of DCC in CH2Cl2 (1.2 mL) previously diluted with anhy-
drous Et2O (4 mL) was added dropwise for 10 min. The white suspension that was
produced was continuously stirred at RT for 12 h. Afterward, the mixture was
filtered, and the filtrate was evaporated in vacuo to afford a white solid. The
corresponding dodecanoic anhydride was dried under high vacuum for 3 h and
used without further purification.
5′-AMP.H2O (147.8 mg, 0.40 mmol) was dissolved in a solution of 8 mL of 1:1
H2O:pyridine (v/v) containing NaOH (20 mg, 0.50 mmol) taken in a long vessel.
Following this, a solution of dodecanoic anhydride dissolved in 8 mL of THF was
added to the mixture in three portions. Upon addition, a white suspension formed
readily, and the mixture was stirred at RT continuously. In about 15 min, the
suspension turned into nearly clear solution. Next, Et2O (20 mL) was added and
the two-phase mixture was stirred vigorously for about 2 min. Then, the two-phase
system was allowed to rest briefly and the upper phase was removed carefully. This
process was repeated three times. After this, a small volume of distilled water (~3
mL) was added, and the pH was lowered to ∼3 by dropwise addition of aqueous
HCl (5%). The gel was transformed into a white suspension and Et2O (3 × 15 mL)
was used to extract the latter by vigorous stirring. The top organic layer is separated
continuously after each round. The white solid was transferred to a Büchner funnel
and the residual suspension was filtered. Finally, the solid is washed with acetone
(3 × 5 mL) and Et2O (2 × 5mL). The residue is dried in vacuo, and dodecanoyl-
AMP 1 is obtained as a white powder [125.2 mg, 60%]. 1H NMR (d6-DMSO,
500.13 MHz, δ): 8.55 (s, 1 H, 1 × CHAr), 8.30 (s, 1 H, 1 × CHAr), 5.94 (d, J= 5.6 Hz,
1 H, 1 × CH), 4.57 (t, J= 5.3 Hz, 1 H, 1 × CH), 4.24–3.98 (m, 4 H, 2 × CH+ 1 ×
CH2), 2.33 (t, J= 7.3 Hz, 2 H, 1 × CH2), 1.55–1.35 (m, 2 H, 1 × CH2), 1.31–1.09 (m,
16 H, 8 × CH2), 0.88 (t, J= 6.8 Hz, 3 H, 1 × CH3). 13C NMR (d6-DMSO, 125.77
MHz, δ): 163.3, 152.8, 148.8, 148.5, 140.8, 118.7, 87.3, 83.6, 73.8, 70.4, 66.0, 34.6,
31.3, 29.0, 29.0, 28.9, 28.7, 28.7, 28.3, 24.1, 22.1, 14.0. MS (ESI-TOF) [m/z (%)]: 530
([MH]+, 100). HRMS (ESI-TOF) calculated for C22H37N5O8P ([MH]+) 530.2374,
found 530.2374.
Expression and purification of His6-tagged FadD10. The fadD10 (Rv0099)-
pDEST17 plasmid was transformed into Novagen BL21(DE3) competent E. coli
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cells and grown overnight at 37 °C in Luria-Bertani (LB) broth containing
0.1 mg/mL of ampicillin. Afterward, 1 mL of the overnight culture was used to
inoculate 1 L of freshly autoclaved LB medium containing 0.1 mg/mL of ampicillin.
The rest of the overnight culture was stored as 25% glycerol stocks at −80 °C. The
culture was grown at 37 °C in a shaker-incubator till the OD600 reached about 0.7.
Overexpression of FadD10 was induced by addition of 1 mM isopropyl 1-thio-D-
galactopyranoside (IPTG). The cells were then grown for 18–20 h at 18 °C, after
which the cells were harvested by centrifuging at 6000 rcf for 20 min at 4 °C. The
pellet was resuspended by vortexing in 10 mL of lysis buffer containing 25 mM
Tris pH 8.0, 0.5 M NaCl, 2 mM β-mercaptoethanol, 1 mg/mL lysozyme and a
cocktail of protease inhibitors (SigmaFast®). Following cell lysis by an ultra-
sonicator probe, debris were removed by centrifuging (13,000 rcf, 20 min, 4 °C).
The supernatant was incubated in a gravity column with Ni2+-nitrilotriacetate
(Ni-NTA) agarose resin pre-equilibrated with 10 mM imidazole on a shaker table
for 3 h at 4 °C. Next, the flow-through was discarded and the resin was washed with
10 mL each of 20 mM imidazole and 50 mM imidazole solutions. Finally, His6-
tagged FadD10 was eluted with 250 mM imidazole and collected in 1 mL fractions
and the pure fractions were pooled and concentrated using 30 kDa MWCO cen-
trifuge filters at 4 °C. They were stored in small aliquots containing 10% glycerol
each (final concentration: 6.75 mg/mL) and stored at −80 °C.
De novo phospholipid formation mediated by FadD10. In a typical de novo
phospholipid synthesis reaction, to a 2.0 µL of lysolipid 2 solution (10 mM stock in
H2O) were successively added 2 µL HEPES (1 M), 1.8 µL of MgCl2 (100 mM stock
solution), 0.6 µL of ATP (100 mM stock solution) and 9.6 µL of H2O. Next, 3.3–13
µg of FadD10 (from a 10% glycerol stock, 6.75 mg/mL) were added, and the
solution was mixed by gentle tapping. Afterward, 2.0 µL of dodecanoic acid (as 10
mM sodium dodecanoate stock solution) were added. The reaction mixture was
kept incubated in a 37 °C water bath. Small aliquots (~2 µL) were taken out at
various time points and placed on a glass slide for microscopic observations. We
found that the pH range 7.5–8.5 is optimum for vesicle formation. Below pH 7.5,
vesicle formation was impaired due to aggregation caused by poor solubility of
dodecanoic acid. Above pH 8.5, the amino-lysolipids and phospholipids had
reduced stability due to hydrolysis at the sn2 position. We carried out in situ vesicle
formation experiments in the concentration range 0.1–1.0 mM of the amphiphilic
precursors (see Supplementary Fig. 8 for representative images).
FRET assay for de novo phospholipid membrane formation. A phospholipid
synthesis reaction was setup using 0.5 mM lysolipid 2, 0.5 mM sodium dode-
canoate, 7.5 mM MgCl2, 2.5 mM ATP, and FadD10 in HEPES buffer (pH 8.0, 100
mM) in presence of 0.5 µM of each of the FRET dyes NBD-DHPE (donor; λem: 530
nm) and Rhodamine-DHPE (acceptor; λem: 586 nm). The reaction mixture was
placed in a 384-well plate at 37 °C. Four hundred and thirty nanometers (band-
width: 7.5 nm) were used as the wavelength for excitation, and emission was
monitored at 530 nm (bandwidth: 7.5 nm) and 586 nm (bandwidth: 7.5 nm). The
ratio of the fluorescence intensities at 530 nm and 586 nm was calculated and
plotted with time. In a control experiment, ATP was substituted with GTP and
fluorescence measurements were carried out using same parameters.
Microfluidics experiments. Giant vesicles were prepared by adding the following
components in the given order: 20 µL lysolipid 2 (10 mM in 50 mM HEPES pH 7.5
buffer), 9 µL MgCl2 (100 mM), 3 µL ATP (100 mM), 20 µL ddH2O, 20 µL 100 mM
HEPES pH 7.5 buffer, 6.5 µL FadD10 (6.75 mg/mL), 1.5 µL Alexa Fluor® 488-
labeled FadD10 (14 µM), 0.5 µL Texas Red® DHPE (100 µM in EtOH), and 20 µL
FAA 1 (10 mM in 50mM HEPES pH 7.5 buffer). The reaction mixture was placed
in a glass vial and stirred at RT for 2 h, obtaining phospholipid 3 vesicles encap-
sulating FadD10. We also carried out vesicle formation following the described
procedure in presence of 0.1 mM TNP-ATP, a surrogate of ATP that binds to ATP-
binding proteins resulting in marked increase in fluorescence intensity. We
observed that the fluorescence intensity is significantly higher inside the vesicles
compared with the background (Supplementary Fig. 13f), suggesting that FadD10
is encapsulated highly efficiently in functional form.
Long-term vesicle growth was observed in a microfluidic device fabricated from
polydimethylsiloxane (PDMS) and plasma bonded to cover glass. Pre-formed
vesicles were vacuum-loaded into chambers that were 230-µm wide, 230-µm long,
and 80-µm high. The chip was then connected to a reservoir of precursor solution
(40 µM lysolipid 4, 40 µM sodium dodecanoate, 3 mM ATP, 9 mM MgCl2, 40 mM
HEPES pH 7.5 buffer) and placed in a temperature-controlled microscope box at
37 °C. In each experiment, the osmolarities of the vesicle solution and the flow
solution were measured and adjusted by adding glycerol accordingly prior to
loading using an osmometer. Precursor solution flow was started immediately after
the first image of the time-lapse Supplementary Movies were acquired. Flow was
regulated to ~20 µL/h using air pressure. Precursors flowing in the main channel of
the device entered vesicle chambers by diffusion through connections that were 50-
µm wide, 60-µm long, and 50-µm high. This architecture allows observation of
vesicles under shear-free conditions without convective flow while ensuring a
constant supply of precursors, which are expected to completely equilibrate within
10 min. Alternatively, in the case of control experiments, lysolipid 4 was replaced
by 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (Lyso C16:0 PC-OH).
De novo phospholipid formation in PURExpress® System. In a typical 10 µL
protein expression reaction, the following components were added in the given order:
4 µL of Solution A (containing amino acids, energy factors, etc.), 3 µL of Solution B
(containing ribosomes, aminoacyl tRNA synthetases, etc), 0.2 µL (4U) murine RNase
inhibitor (New England Biolabs), x µL nuclease-free H2O, y µL DNA. Initially, protein
expression was optimized using different amounts of FadD10 DNA: 50 ng, 100 ng, 150
ng, and 200 ng. A negative control (no DNA) and a positive control (50 ng DHFR
DNA) experiment was also carried out at the same time. All reaction mixtures were
incubated in a 37 °C water bath for 3 h and then analyzed by SDS–PAGE. In total, 2.5
µL of each reaction mixture was loaded onto a precast 4–20% polyacrylamide gel (Mini
Protean, Bio-Rad). The gel was run for 50min at 130V and then stained with Coo-
massie Blue (Instant Blue®, CBS Scientific) for 1 h. The stained gel was washed with
distilled water and imaged with a commercial scanner. Expression of FadD10 was
observed as expected. It was found that 50 ng DNA was sufficient for a 5 µL protein
expression reaction for FadD10. Increasing the amount of DNA did not lead to any
significant change in the protein expression (Supplementary Fig. 16a). Expression of
sfGFP-FadD10 was carried out in a similar manner and monitored using spectro-
fluorimetrically (Supplementary Fig. 17b).
For phospholipid synthesis reactions, FadD10 was first expressed in
PURExpress® System with the total reaction volume as 10 µL. A mixture containing
precursors for lipid synthesis was prepared by adding 1.25 µL lysolipid 2 (5 mM),
0.25 µL sodium dodecanoate (25 mM), 1.0 µL ATP (100 mM), 2.0 µL MgCl2 (100
mM), and 10.5 µL 100 mM HEPES pH 8.0 buffer. Then, it was added to the
PURExpress® System solution, and the resulting reaction mixture was further
incubated at 37 °C for 3 h with tumbling. Afterward, 25 µL of MeOH was added to
the reaction mixture, which cause formation of a white precipitate. The precipitate
was separated by brief centrifugation, and the supernatant was collected and
injected into HPLC-ELSD-MS. Formation of phospholipid 3 was confirmed from
the retention time and verified by mass spectrometry. In separate experiments, it
was also found that higher concentrations of phospholipid 3 (tested up to 1 mM)
can be synthesized, albeit with longer incubation times (up to 12 h). Alternatively,
in a control experiment, where FadD10 DNA was omitted in the first step, no
phospholipid formation was observed.
Synthesis of phospholipid 3 (in the concentration range 0.25–1.0 mM) was
carried out in PURExpress® System as described before using FadD10 and sfGFP-
FadD10 plasmids. Vesicle formation can be improved and aggregate formation can
be minimized by tumbling, occasional mild vortexing, and tapping the reaction
tube. Longer incubation time (24 h) was required when lipid synthesis (0.5 mM)
was carried out using sfGFP-FadD10 plasmid. The membranes were stained using
0.1 mol% Texas Red® DHPE. An aliquot of the corresponding sample was placed
on a glass slide and observed using fluorescence microscopy. In a control
experiment where no DNA was added in the beginning, vesicles were not observed.
Cryogenic-transmission electron microscopy (Cryo-TEM). Copper grids
(Quantifoil R2/2, 300 mesh copper; 2 µm hole/2-µm spacing) were treated in the
beginning with CHCl3 for 4 h to get rid of residual plastic. Later, they were dried,
and their surfaces were glow discharged at 20 mA for 30 s using an Emitech K950X
instrument with a K350 glow discharge unit. Once the surface for vesicle adhesion
is ready, samples were vitrificated by plunge-freezing using the commercial
environmentally controlled automated Vitrobot (FEI, The Netherlands) at a con-
trolled temperature of 4 °C and ≈95% humidity [Conditions Vitrobot: 1 blot, with
4 s blot time using standard Vitrobot filter paper, ϕ55/20 mm, Grade 595; Blot
force: 0, Drain time: 0]42. A 3.5 μL of in situ formed phospholipid 3 vesicles was
deposited on the grid surface. This solution was allowed to sit for 4 s. After this, the
grids were blotted on both sides using Teflon sheets from reverse and on the
backside by using filter paper. Next, they were plunged into the liquid ethane
immediately at the temperature of liquid nitrogen. On imaging by cryo-TEM,
spherical compartments were detected in accordance with the vesicle architecture.
Reporting Summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this Article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its Supplementary Information files, and, also available from
the corresponding author upon reasonable request.
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